Evidence map›Paper›PMID 34115105›Full record

ArticleBrain : a journal of neurology2021

TDP-43 stabilizes G3BP1 mRNA: relevance to amyotrophic lateral sclerosis/frontotemporal dementia.

Hadjara Sidibé, Yousra Khalfallah, Shangxi Xiao, Nicolás B Gómez, Hana Fakim, Elizabeth M H Tank, Geneviève Di Tomasso, Eric Bareke, Anaïs Aulas, Paul M McKeever and 10 more

Open access · greenAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Consequences of the Novel ALS-AssociatedNeurology. Genetics · 2026
    Article
  9. Article
  10. Neurodegenerative spliceosomopathies.Frontiers in cell and developmental biology · 2026
    Review
  11. Review
  12. Article
  13. Dissolving stress granules.Nature chemical biology · 2025
    Article
  14. Article
  15. ALKBH5-Mediated MAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Hadjara SidibéDepartment of Neurosciences, Université de Montréal, Montréal, QC H3A 0E8, Canada.
Yousra KhalfallahCHUM Research Center, Montréal, QC H2X 0A9, Canada.
Shangxi XiaoTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 0S8, Canada.
Nicolás B GómezDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Hana FakimDepartment of Neurosciences, Université de Montréal, Montréal, QC H3A 0E8, Canada.
Elizabeth M H TankDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Geneviève Di TomassoDepartment of Biochemistry, Université de Montréal, Montréal, QC H3A 0E8, Canada.
Eric BarekeCHUM Research Center, Montréal, QC H2X 0A9, Canada.
Anaïs AulasCHUM Research Center, Montréal, QC H2X 0A9, Canada.
Paul M McKeeverTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 0S8, Canada.ORCID 0000-0002-9464-141X
Ze'ev MelamedUniversity of California, San Diego/Ludwig Institute for Cancer Research, San Diego, CA 92093, USA.
Laurie DestroimaisonsCHUM Research Center, Montréal, QC H2X 0A9, Canada.
Jade-Emmanuelle DeshaiesCHUM Research Center, Montréal, QC H2X 0A9, Canada.
Lorne ZinmanDivision of Neurology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON M4N 3M5, Canada.
J Alex ParkerDepartment of Neurosciences, Université de Montréal, Montréal, QC H3A 0E8, Canada.
Pascale LegaultDepartment of Biochemistry, Université de Montréal, Montréal, QC H3A 0E8, Canada.ORCID 0000-0003-1782-5204
Martine TétreaultDepartment of Neurosciences, Université de Montréal, Montréal, QC H3A 0E8, Canada.
Sami J BarmadaDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0002-9604-968X
Janice RobertsonTanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON M5T 0S8, Canada.
Christine Vande VeldeDepartment of Neurosciences, Université de Montréal, Montréal, QC H3A 0E8, Canada.ORCID 0000-0001-5926-1529
Centre Hospitalier de l’Université de Montréal · CAUniversity of Michigan · USUniversity of Toronto · CAUniversité de Montréal · CASunnybrook Health Science Centre · CAUniversity of California San Diego · US

Funding

Research Education ComponentP30AG072931 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DOUGLAS C NOLL · 2021 to 2026
$26.5M
CELLULAR AND MOLECULAR BIOLOGY AT MICHIGANT32GM007315 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PUTHENVEEDU, MANOJKUMAR A · 1985 to 2021
$12.8M
Michigan Alzheimer's Disease Core CenterP30AG053760 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALBIN, ROGER L · 2016 to 2020
$10.1M
RNA decay in amyotrophic lateral sclerosis and frontotemporal lobar degenerationR01NS097542 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARMADA, SAMI · 2016 to 2025
$3.8M
Atypical TDP43 isoforrms driving neurodegeneration in FTD/ALSR01NS113943 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BARMADA, SAMI · 2020 to 2024
$1.9M
NIA NIH HHS P30 AG053760NIA NIH HHS P30 AG072931NIGMS NIH HHS T32 GM007315NINDS NIH HHS R01 NS097542NINDS NIH HHS R01 NS113943
6 · The paper itself

Abstract

TDP-43 nuclear depletion and concurrent cytoplasmic accumulation in vulnerable neurons is a hallmark feature of progressive neurodegenerative proteinopathies such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Cellular stress signalling and stress granule dynamics are now recognized to play a role in ALS/FTD pathogenesis. Defective stress granule assembly is associated with increased cellular vulnerability and death. Ras-GAP SH3-domain-binding protein 1 (G3BP1) is a critical stress granule assembly factor. Here, we define that TDP-43 stabilizes G3BP1 transcripts via direct binding of a highly conserved cis regulatory element within the 3' untranslated region. Moreover, we show in vitro and in vivo that nuclear TDP-43 depletion is sufficient to reduce G3BP1 protein levels. Finally, we establish that G3BP1 transcripts are reduced in ALS/FTD patient neurons bearing TDP-43 cytoplasmic inclusions/nuclear depletion. Thus, our data indicate that, in ALS/FTD, there is a compromised stress granule response in disease-affected neurons due to impaired G3BP1 mRNA stability caused by TDP-43 nuclear depletion. These data implicate TDP-43 and G3BP1 loss of function as contributors to disease.

Indexed as

Amyotrophic Lateral SclerosisCells, CulturedDNA-Binding ProteinsDNA HelicasesFrontotemporal DementiaHumansNeuronsPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA, MessengerRNA Recognition Motif ProteinsDNA-Binding ProteinsDNA HelicasesG3BP1 protein, humanPoly-ADP-Ribose Binding ProteinsRNA HelicasesRNA, MessengerRNA Recognition Motif ProteinsTARDBP protein, humanamyotrophic lateral sclerosisfrontotemporal dementiaG3BP1stress granulesTDP-43

Identifiers

PMID34115105
PMCPMC8677511
OpenAlexW3167256638

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.